StockMarketWire.com - Cell-based therapeutics ReNeuron said it had entered a collaboration agreement with University College London.

The two groups would conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies.


Story provided by StockMarketWire.com